Utah Medical Products Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 113/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Utah Medical Products Inc's Score
Industry at a Glance
Industry Ranking
113 / 208
Overall Ranking
270 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Utah Medical Products Inc Highlights
StrengthsRisks
Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
Growing
The company is in a growing phase, with the latest annual income totaling USD 40.90M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 30.19%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 30.19%.
Fairly Valued
The company’s latest PE is 15.98, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.27M shares, decreasing 21.91% quarter-over-quarter.
Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
Ticker SymbolUTMD
CompanyUtah Medical Products Inc
CEOCornwell (Kevin L)
Websitehttp://www.utahmed.com
FAQs
What is the current price of Utah Medical Products Inc (UTMD)?
The current price of Utah Medical Products Inc (UTMD) is 56.610.
What is the symbol of Utah Medical Products Inc?
The ticker symbol of Utah Medical Products Inc is UTMD.
What is the 52-week high of Utah Medical Products Inc?
The 52-week high of Utah Medical Products Inc is 65.560.
What is the 52-week low of Utah Medical Products Inc?
The 52-week low of Utah Medical Products Inc is 51.260.
What is the market capitalization of Utah Medical Products Inc?
The market capitalization of Utah Medical Products Inc is 181.38M.
What is the net income of Utah Medical Products Inc?
The net income of Utah Medical Products Inc is 13.87M.
Is Utah Medical Products Inc (UTMD) currently rated as Buy, Hold, or Sell?
According to analysts, Utah Medical Products Inc (UTMD) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Utah Medical Products Inc (UTMD)?
The Earnings Per Share (EPS TTM) of Utah Medical Products Inc (UTMD) is 3.543.